Ma Nowemapa 20, 2020, ua hoʻopaʻa inoa ʻo Foregene Co., Ltd. a me Shenzhen Shangyang Asset Management Co., Ltd. (i kapa ʻia ʻo Shenzhen Shangyang) i kahi ʻaelike hoʻokele waiwai.Ua hana ʻo Shenzhen Shangyang i kahi hoʻopukapuka A he mau miliona RMB ma Foregene, a ua hoʻopau ʻia ke kālā i kēia manawa.

Ua hoʻokumu ʻia ʻo Foregene Co., Ltd. i ʻApelila 2011. Ke kālele nei ka hui i ka ʻenehana molecular biology hou R&D a me ka hoʻomohala huahana.ʻO ka ʻenehana patent PCR Direct i hoʻomohala ʻia e Foregene e alakaʻi i ka ʻoihana a loaʻa iā ia nā manaʻo noi nui ma ke kahua o ka diagnostics molecular.I ka makahiki 2016, ua koho ʻo Foregene i ke kolu o ka lāʻau lapaʻau hou o Chengdu Medical City, Wenjiang District, Chengdu, a hoʻokumu i kahi ʻoihana nona piha, Chengdu Forge Biotechnology Co., Ltd. (www.foreivd.com).ʻO ka hoʻololi ʻana i ke kahua o nā diagnostics molecular.Ua loaʻa i ka hui kekahi mau patent invention home a me nā patent honua.Ma muli o ka ʻenehana PCR Direct, ua kūkulu ʻo Foregene i "15 respiratory system pathogenic bacteria detection kit".Hiki i ka pahu ke ʻike i 15 mau ʻano bacteria pathogenic i ka sputum me ka ʻole o ka hoʻomaʻemaʻe ʻana i ka waikawa nucleic i loko o ka sputum.Ma hope o ka hōʻoia ʻana me kekahi mau ʻoihana olakino kaulana, ʻoi aku ka maikaʻi o ka hana o ka pahu ma mua o nā ʻano kuʻuna kuʻuna o ka moʻomeheu sputum.Ma ke ʻano o ka pono, hoʻopōkole ia i ka 3 a 5 mau lā i 1.5 mau hola.Manaʻo ʻia ma hope o ka ʻae ʻia ʻana o ka huahana no ke kūʻai aku ʻana, e hoʻokumu ia i kahi hōʻailona hou no ka ʻike ʻana i nā pathogen clinical ma ka honua holoʻokoʻa, e hāʻawi i kahi kumu hou no ka mālama pono ʻana i nā maʻi hanu, a kōkua i ka hoʻoponopono ʻana i nā pilikia palekana o ka lehulehu o ka hoʻohana ʻana i ka lāʻau antibiotic a me ka pale ʻana i ka maʻi bacteria.

I ka hoʻomaka ʻana o 2020, i ka pane ʻana i ka maʻi maʻi COVID-19, ua hoʻopau ʻo Foregene i ka hoʻomohala ʻana i kahi pūʻulu piha o nā kits detection nucleic acid hou i nā lā 4 wale nō, e lilo ana i hoʻokahi o nā hui mua ʻelua ma ke komohana Kina e hoʻomohala i kēia huahana.ʻAʻole pono nā kits a Foregene e hoʻomaʻemaʻe i ka waikawa nucleic viral e ʻike ai i ka waikawa nucleic coronavirus hou.I kēia manawa, ua lawe ʻia ka pahu i nā ʻāina he nui me Sepania, Farani, Iran, Brazil, Bangladesh, Indonesia, Kazakhstan, etc.
Ua hoʻokumu ʻia ʻo Shenzhen Shangyang Asset Management Co., Ltd. ma Ianuali 26, 2016. He mea hoʻokele waiwai pilikino i hoʻopaʻa inoa ʻia me ka China Fund Association.Mai kona hoʻokumu ʻia ʻana i ka makahiki 2016, ua komo pū ka hui i ka hoʻokele ʻana i nā kālā kaulike he nui a me nā papahana waihona kālā ʻoihana, me ka nui o ka hoʻokele kumulative ʻoi aku ma mua o 2 biliona yuan.ʻO nā kahua hoʻopukapuka e pili ana i ka hana lāʻau lapaʻau, ka hāʻawi ʻana i ka lāʻau lapaʻau, ka waiwai hoʻokele moʻomeheu a me nā kaʻa ikehu hou, etc.

Ma muli o nā ʻenehana diagnostic molecular hou aʻe me ka ʻenehana Direct PCR, e hoʻomau ʻo Foregene i ka hoʻomohala ʻana i nā huahana ʻike microorganism pathogenic a me nā huahana kākoʻo, a ke nānā nei i ka hāʻawi ʻana i ka naʻauao a me ka ikaika o Foregene i ke olakino kanaka.